These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 14603670)

  • 41. [Review of randomized trials of angiotensin receptor blockers in the treatment of patients with congestive heart failure].
    Rakugi H; Ogihara T
    Nihon Rinsho; 2001 Oct; 59(10):2051-61. PubMed ID: 11676153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Benefits of candesartan in the treatment of symptomatic heart failure--CHARM programme].
    Umemoto S; Matsuzaki M
    Nihon Rinsho; 2004 Jan; 62(1):211-8. PubMed ID: 14737855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New treatment of heart failure. Angiotensin II receptor blockaders show promising results in an extensive study].
    Dahlström U
    Lakartidningen; 2004 Feb; 101(9):742-3. PubMed ID: 15045837
    [No Abstract]   [Full Text] [Related]  

  • 44. The CHARM programme.
    Möller BH
    Lancet; 2003 Nov; 362(9396):1677-8; author reply 1678-9. PubMed ID: 14630457
    [No Abstract]   [Full Text] [Related]  

  • 45. HEAAL: the final chapter in the story of angiotensin receptor blockers in heart failure--lessons learnt from a decade of trials.
    McMurray JJ; Swedberg K
    Eur J Heart Fail; 2010 Feb; 12(2):99-103. PubMed ID: 20083618
    [No Abstract]   [Full Text] [Related]  

  • 46. [Heart failure in hypertension in the elderly].
    Seto S
    Nihon Rinsho; 2005 Jun; 63(6):1041-6. PubMed ID: 15948388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Organ protection by angiotensin II receptor blockers].
    Kumagai H; Onami T; Takimoto C; Iigaya K; Saruta T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():569-73. PubMed ID: 15171437
    [No Abstract]   [Full Text] [Related]  

  • 48. [Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker].
    Schindler C; Kosa M; Schröder J; Kirch W
    Dtsch Med Wochenschr; 2010 May; 135(3):98. PubMed ID: 20077385
    [No Abstract]   [Full Text] [Related]  

  • 49. A review of the current evidence for the use of angiotensin-receptor blockers in chronic heart failure.
    Erhardt LR
    Int J Clin Pract; 2005 May; 59(5):571-8. PubMed ID: 15857354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [ACE inhibitors, beta blockers, AT-1 antagonists in heart failure. Right dosage and combination].
    Fliri M
    MMW Fortschr Med; 2002 Nov; 144(48):38-43. PubMed ID: 12532542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiotensin receptor blockers in congestive heart failure: evidence, concerns, and controversies.
    Bhatia V; Bhatia R; Mathew B
    Cardiol Rev; 2005; 13(6):297-303. PubMed ID: 16230887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Valsartan in chronic heart failure.
    Campbell DJ
    N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11951863
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapy of heart failure. 2 neurohormone blockers are enough].
    MMW Fortschr Med; 2002 Sep; 144(35-36):57. PubMed ID: 12380364
    [No Abstract]   [Full Text] [Related]  

  • 54. CHARM shows improvement in NYHA functional class with candesartan.
    Cardiovasc J S Afr; 2004; 15(2):96-7. PubMed ID: 15148548
    [No Abstract]   [Full Text] [Related]  

  • 55. Valsartan in chronic heart failure.
    Forfar JC; Munir S
    N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11951862
    [No Abstract]   [Full Text] [Related]  

  • 56. Angiotensin II type 1 receptor blockers and congestive heart failure.
    Auer JW; Berent R; Eber B
    Circulation; 2001 Oct; 104(15):E82. PubMed ID: 11591633
    [No Abstract]   [Full Text] [Related]  

  • 57. The CHARM programme.
    Gama MG; Rocha G
    Lancet; 2003 Nov; 362(9396):1676; author reply 1678-9. PubMed ID: 14630454
    [No Abstract]   [Full Text] [Related]  

  • 58. And an ARB makes nine: polypharmacy in patients with heart failure.
    Stehlik J; Taylor DO
    Cleve Clin J Med; 2004 Aug; 71(8):674-7. PubMed ID: 15449763
    [No Abstract]   [Full Text] [Related]  

  • 59. Heart failure management. Interview with Karl Swedberg.
    Swedberg K
    Timely Top Med Cardiovasc Dis; 2007 Jan; 11():E1. PubMed ID: 17369884
    [No Abstract]   [Full Text] [Related]  

  • 60. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
    MMW Fortschr Med; 2003 Dec; 145(49):18-9. PubMed ID: 14963986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.